Literature DB >> 27470451

Underutilization of Coronary Artery Disease Testing Among Patients Hospitalized With New-Onset Heart Failure.

Darshan Doshi1, Ori Ben-Yehuda2, Machaon Bonafede3, Noam Josephy4, Dimitri Karmpaliotis2, Manish A Parikh1, Jeffrey W Moses2, Gregg W Stone2, Martin B Leon2, Allan Schwartz1, Ajay J Kirtane5.   

Abstract

BACKGROUND: Although ischemic coronary artery disease (CAD) is the most common etiology of heart failure (HF), the extent to which patients with new-onset HF actually undergo an ischemic work-up and/or revascularization is not well defined.
OBJECTIVES: This study sought to analyze the patterns of testing for ischemic CAD and revascularization in patients with new-onset HF.
METHODS: This was a retrospective cohort study using Truven Health MarketScan Commercial and Medicare databases from 2010 to 2013. The occurrence of noninvasive and invasive ischemic CAD testing and revascularization procedures were examined among patients with new inpatient HF diagnoses during the index hospitalization and within 90 days of admission.
RESULTS: Among 67,161 patients identified with new-onset HF during an inpatient hospitalization, only 17.5% underwent testing for ischemic CAD during the index hospitalization, increasing to 27.4% at 90 days. Among patients with new-onset HF, only 2.1% underwent revascularization during the index hospitalization for HF; by 90 days, the revascularization rate had increased to 4.3%. Of the tests performed for ischemic CAD, stress testing (nuclear stress testing or stress echocardiography) was performed in 7.9% of new-onset HF patients during the index hospitalization (14.6% within 90 days), whereas coronary angiography was performed in 11.1% of patients during the index hospitalization (16.5% within 90 days). In adjusted analyses, HF patients carrying a baseline diagnosis of CAD had greater odds of noninvasive ischemic testing (odds ratio: 1.25; 95% confidence interval: 1.17 to 1.33; p < 0.0001), as well as invasive ischemic testing (odds ratio: 1.93; 95% confidence interval: 1.83 to 2.05; p < 0.0001), at the index hospitalization than those without baseline CAD.
CONCLUSIONS: The majority of patients hospitalized for new-onset HF did not receive testing for ischemic CAD either during hospitalization or within 90 days, which suggests significant underutilization of ischemic CAD assessment in new-onset HF patients.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  angiography; invasive; ischemic CAD; noninvasive; revascularization; stress testing

Mesh:

Year:  2016        PMID: 27470451      PMCID: PMC9135048          DOI: 10.1016/j.jacc.2016.05.060

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   27.203


  32 in total

1.  Acute heart failure complicating acute coronary syndromes: a deadly intersection.

Authors:  Eric J Velazquez; Marc A Pfeffer
Journal:  Circulation       Date:  2004-02-03       Impact factor: 29.690

2.  Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.

Authors:  Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sandeep R Das; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Carmen R Isasi; Monik C Jiménez; Suzanne E Judd; Brett M Kissela; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David J Magid; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Wayne Rosamond; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Daniel Woo; Robert W Yeh; Melanie B Turner
Journal:  Circulation       Date:  2015-12-16       Impact factor: 29.690

3.  Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.

Authors:  Anne L Taylor; Susan Ziesche; Clyde Yancy; Peter Carson; Ralph D'Agostino; Keith Ferdinand; Malcolm Taylor; Kirkwood Adams; Michael Sabolinski; Manuel Worcel; Jay N Cohn
Journal:  N Engl J Med       Date:  2004-11-08       Impact factor: 91.245

4.  Heart disease and stroke statistics--2015 update: a report from the American Heart Association.

Authors:  Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Joshua Z Willey; Daniel Woo; Robert W Yeh; Melanie B Turner
Journal:  Circulation       Date:  2014-12-17       Impact factor: 29.690

5.  Long-term trends in the incidence of and survival with heart failure.

Authors:  Daniel Levy; Satish Kenchaiah; Martin G Larson; Emelia J Benjamin; Michelle J Kupka; Kalon K L Ho; Joanne M Murabito; Ramachandran S Vasan
Journal:  N Engl J Med       Date:  2002-10-31       Impact factor: 91.245

6.  Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy.

Authors:  M A Auerbach; H Schöder; C Hoh; S S Gambhir; S Yaghoubi; J W Sayre; D Silverman; M E Phelps; H R Schelbert; J Czernin
Journal:  Circulation       Date:  1999-06-08       Impact factor: 29.690

7.  Coronary-artery bypass surgery in patients with left ventricular dysfunction.

Authors:  Eric J Velazquez; Kerry L Lee; Marek A Deja; Anil Jain; George Sopko; Andrey Marchenko; Imtiaz S Ali; Gerald Pohost; Sinisa Gradinac; William T Abraham; Michael Yii; Dorairaj Prabhakaran; Hanna Szwed; Paolo Ferrazzi; Mark C Petrie; Christopher M O'Connor; Pradit Panchavinnin; Lilin She; Robert O Bonow; Gena Roush Rankin; Robert H Jones; Jean-Lucien Rouleau
Journal:  N Engl J Med       Date:  2011-04-04       Impact factor: 91.245

Review 8.  Epidemiology and risk profile of heart failure.

Authors:  Anh L Bui; Tamara B Horwich; Gregg C Fonarow
Journal:  Nat Rev Cardiol       Date:  2010-11-09       Impact factor: 32.419

9.  Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records.

Authors:  Yuka Kiyota; Sebastian Schneeweiss; Robert J Glynn; Carolyn C Cannuscio; Jerry Avorn; Daniel H Solomon
Journal:  Am Heart J       Date:  2004-07       Impact factor: 4.749

10.  Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).

Authors:  James D Flaherty; Joseph S Rossi; Gregg C Fonarow; Eduardo Nunez; Wendy Gattis Stough; William T Abraham; Nancy M Albert; Barry H Greenberg; Christopher M O'Connor; Clyde W Yancy; James B Young; Charles J Davidson; Mihai Gheorghiade
Journal:  Am Heart J       Date:  2009-04-23       Impact factor: 4.749

View more
  14 in total

1.  Rethinking Revascularization in Left Ventricular Systolic Dysfunction.

Authors:  Adam D DeVore; Eric J Velazquez
Journal:  Circ Heart Fail       Date:  2017-01       Impact factor: 8.790

2.  Demonstrating the Value of Outcomes in Echocardiography: Imaging-Based Registries in Improving Patient Care.

Authors:  Jordan B Strom; Varsha K Tanguturi; Sherif F Nagueh; Allan L Klein; Warren J Manning
Journal:  J Am Soc Echocardiogr       Date:  2019-09-25       Impact factor: 5.251

3.  Variability in Coronary Artery Disease Testing for Patients With New-Onset Heart Failure.

Authors:  Jimmy Zheng; Paul A Heidenreich; Shun Kohsaka; William F Fearon; Alexander T Sandhu
Journal:  J Am Coll Cardiol       Date:  2022-03-08       Impact factor: 27.203

4.  Association of Ischemic Evaluation and Clinical Outcomes Among Patients Admitted With New-Onset Heart Failure.

Authors:  Erin McGuinn; Theodore Warsavage; Mary E Plomondon; Javier A Valle; P Michael Ho; Stephen W Waldo
Journal:  J Am Heart Assoc       Date:  2021-02-15       Impact factor: 5.501

5.  Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention.

Authors:  Ajay J Kirtane; Darshan Doshi; Martin B Leon; John M Lasala; E Magnus Ohman; William W O'Neill; Adhir Shroff; Mauricio G Cohen; Igor F Palacios; Nirat Beohar; Nir Uriel; Navin K Kapur; Dimitri Karmpaliotis; William Lombardi; George D Dangas; Manish A Parikh; Gregg W Stone; Jeffrey W Moses
Journal:  Circulation       Date:  2016-08-02       Impact factor: 39.918

6.  Incidence and Prognostic Implications of Readmissions Caused by Thrombotic Events After a Heart Failure Hospitalization.

Authors:  Pulkit Chaudhury; Paulino Alvarez; Madonna Michael; Marwan Saad; G Jay Bishop; Mazen Hanna; Venu Menon; Randall C Starling; Alex C Spyropoulos; Milind Desai; Amgad Mentias
Journal:  J Am Heart Assoc       Date:  2022-05-10       Impact factor: 6.106

7.  Identification of 15 novel risk loci for coronary artery disease and genetic risk of recurrent events, atrial fibrillation and heart failure.

Authors:  Niek Verweij; Ruben N Eppinga; Yanick Hagemeijer; Pim van der Harst
Journal:  Sci Rep       Date:  2017-06-05       Impact factor: 4.379

Review 8.  PET-CMR in heart failure - synergistic or redundant imaging?

Authors:  Michael A Quail; Albert J Sinusas
Journal:  Heart Fail Rev       Date:  2017-07       Impact factor: 4.214

9.  Potentially harmful drug prescription in elderly patients with heart failure with reduced ejection fraction.

Authors:  Paulino A Alvarez; Yubo Gao; Saket Girotra; Amgad Mentias; Alexandros Briasoulis; Mary S Vaughan Sarrazin
Journal:  ESC Heart Fail       Date:  2020-05-17

10.  Impact of left-ventricular end-diastolic pressure as a predictor of periprocedural hemodynamic deterioration in patients undergoing Impella supported high-risk percutaneous coronary interventions.

Authors:  Fadi Al-Rashid; Amir A Mahabadi; Laura Johannsen; Julian Soldat; Iryna Dykun; Rolf Alexander Jánosi; Matthias Totzeck; Tienush Rassaf
Journal:  Int J Cardiol Heart Vasc       Date:  2019-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.